2nd Edition of International Cancer Research Conference
March 19-21, 2026 | Singapore
Future Directions in Cancer Research
- Liquid Tumor Models and In Silico Simulations
- Metabolism and Cancer: Novel Therapeutic Targets
- Emerging Trends in Oncolytic Virus Therapy
- Exploring the Role of Microbiome in Cancer
The future of cancer research holds immense promise with advancements in personalized medicine, immunotherapy, and early detection technologies. One of the most exciting directions is the development of targeted therapies, which aim to treat cancer by identifying and attacking specific cancer cells without harming healthy tissue. Immunotherapy, which harnesses the body's immune system to fight cancer, is also showing great potential, especially with innovative approaches like CAR T-cell therapy. Moreover, the integration of artificial intelligence in research is speeding up drug discovery and diagnosis, enabling more accurate predictions and treatment plans. Finally, precision medicine and genetic research are paving the way for individualized cancer treatments, offering hope for better outcomes and more effective therapies in the future.
Rajvir Dahiya
University of California San Francisco, United States
Anyou Wang
DIFIBER LLC, United States
Michael Thompson
University of Toronto, Canada
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Eleni Petsalaki
University of Crete, Greece
Can Küçük
Dokuz Eylul University, TurkeySubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : Uncovering tumor-suppressive roles of histone modifiers in gastric cancer through spatial transcriptomics and epigenomics
Shilpa S Dhar, UT MD Anderson Cancer Center, United States
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : A case-based approach using IMPeTUs criteria in FDG PET/CT reporting of multiple myeloma
Mudalsha Ravina, All India Institute of Medical Sciences, India
Title : Updates on controversies surrounding the staging and management of newly diagnosed localized prostate cancer using prostate-specific membrane antigen (PSMA) positron emission tomography
Patricia Tai, University of Saskatchewan, Canada
Title : A pioneering, first-of-its-kind Canadian off-site program designed to reduce the burden on hospital staff and optimize the use of space
Patricia Tai, University of Saskatchewan, Canada